OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Borgen on the Negative Effects of Pinkwashing

March 20th 2012

Dr. Patrick Borgen, from the Maimonides Breast Cancer Center, Discusses the Negative Effects of Pinkwashing

Dr. Wierda Discusses Watchful Waiting in CLL

March 14th 2012

Dr. William Wierda, from the MD Anderson Cancer Center, Discusses Watchful Waiting in CLL

Dr. Perez-Soler on the Future of Lung Cancer Therapies

March 13th 2012

Dr. Roman Perez-Soler, from Albert Einstein College of Medicine, on the Future of Lung Cancer Therapies

Dr. Jagannath Discusses the VANTAGE Trials

March 12th 2012

Dr. Sundar Jagannath, from Mount Sinai Medical Center, Discusses the VANTAGE Trials

Dr. Schnabel Discusses the DCIS Recurrence Score

March 9th 2012

Dr. Freya Schnabel from NYU School of Medicine Discusses the DCIS Recurrence Score

Dr. Harvey Discusses Preventing Breast Cancer

March 8th 2012

Dr. Harold Harvey from Penn State Hershey Cancer Institute Discusses Preventing Breast Cancer

Dr. Ansell on Waldenstrom Macroglobulinemia Symptoms

March 8th 2012

Dr. Stephen Ansell from the Mayo Clinic in Minnesota Describes Waldenstrom Macroglobulinemia Symptoms

Dr. Belani Discusses Driver Mutations in NSCLC

March 7th 2012

Dr. Chandra Belani from Penn State Hershey Cancer Institute Discusses Driver Mutations in NSCLC

Dr. Ramaswamy Discusses Tumor Heterogeneity

March 7th 2012

Dr. Sridhar Ramaswamy from the Massachusetts General Hospital Cancer Center Discusses Tumor Heterogeneity

Dr. Baselga Discusses the BOLERO Breast Cancer Trials

March 5th 2012

Dr. Jose Baselga from Massachusetts General Hospital Discusses the BOLERO Breast Cancer Trials

Dr. William Wierda Discusses Diagnosing CLL

March 5th 2012

Dr. William Wierda, from MD Anderson Cancer Center, on Diagnosing Chronic Lymphocytic Leukemia

Dr. Mesa Discusses JAK Inhibitors for Myelofibrosis

March 2nd 2012

Dr. Ruben Mesa from the Mayo Clinic in Arizona Discusses JAK Inhibitors for Myelofibrosis

Dr. Birrer on the Ovarian Cancer Avastin OS Benefit

March 2nd 2012

Dr. Michael Birrer from Massachusetts General Hospital Cancer Center on the Ovarian Cancer Avastin OS Benefit

Dr. Gomella on the Cost of the Immunotherapy Sipuleucel-T

March 1st 2012

Dr. Leonard Gomella from the Jefferson Kimmel Cancer Center on the Cost of the Immunotherapy Sipuleucel-T

Dr. Jagannath on HDAC Inhibitors for Multiple Myeloma

February 29th 2012

Dr. Sundar Jagannath from the Tisch Cancer Institute Discusses HDAC Inhibitors for Multiple Myeloma

Dr. Solin on Personalizing Treatment With the DCIS Score

February 28th 2012

Dr. Lawrence Solin from Einstein Medical Center on Personalizing Treatment With the DCIS Score

Dr. Petrylak Discusses the Isotope Radium-223

February 28th 2012

Dr. Daniel Petrylak, from the Herbert Irving Comprehensive Cancer Center, Discusses the Isotope Radium-223

Dr. Burris on Using Recurrence Scores to Predict pCR

February 23rd 2012

Dr. Howard Burris from Sarah Cannon Research Institute Discusses Recurrence Scores Predicting pCR

Dr. Perez Discusses Optimizing Adjuvant Therapy

February 22nd 2012

Dr. Edith Perez from the Mayo Clinic Cancer Center Discusses Optimizing Adjuvant Therapy

Dr. Schnabel on Predicting Breast Cancer by Atypia Type

February 21st 2012

Dr. Freya Schnabel from NYU School of Medicine on Predicting Breast Cancer by Atypia Type